Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 October 2020 | Story Nitha Ramnath

The National Student Entrepreneurship Week (#SEW2020) is a project of Entrepreneurship Development in Higher Education (EDHE) in collaboration with Universities South Africa (USAf). 

The University of the Free State (UFS) has been selected to host the National Student Entrepreneurship Week from 2 to 4 November 2020. The programme is presented virtually and will be streamed by the UFS from 2 to 4 November; the events can be accessed live on the Whova app and on Facebook: @EDHEStudententrepreneurship, allowing students to watch at their convenience.

Background of SEW 2020

The National Student Entrepreneurship Week was piloted in 2017 and successfully executed in 2018 by the public universities and TVET colleges. This year, themed #AfroTech, #SEW2020 aims to gain participation from all (26) public universities and TVET colleges.

Objectives of SEW 2020

The objectives of Student Entrepreneurship Week are to raise awareness among students that participation in the economy is not necessarily only through the avenue of formal employment. Students are encouraged to develop innovative and creative ideas to solve many problems facing society. This year, the event allows universities and TVET colleges to showcase the different entrepreneurial activities and achievements of their institutions, which are intended to raise awareness and inspire students towards entrepreneurship and emphasising the benefits of having the best of both worlds as a student and as an entrepreneur.

Format of event

The event promises to offer a high-impact experience that will be easily accessible virtually, with multi-institutional participation and collaboration nationally. Participating universities will contribute to the content of the programme, which will be curated by the EDHE and livestreamed by the EDHE production partner.

The virtual format of the event allows students to preselect sessions in order to create a personalised experience that is customised for their personal schedules and circumstances. Students can watch the live stream as well as missed sessions on YouTube, and further engage with their own institution or with EDHE on social media.

More information on the Student Entrepreneurship Week can be found at  https://edhe.co.za/

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept